RecruitingNCT07099469

Compairing R-ICNB and C-ICNB for Postoperative Pain Management After Minimal-invasive Anatomical Lung Resection

A Randomized Pilot Study of ICNB With Ropivacaine Versus ICNB With Cryotherapy for Postoperative Pain Management After RATS Anatomical Resection for Lung Cancer.

Sponsor

University Hospital, Antwerp

Enrollment

6 participants

Start Date

Mar 25, 2025

Study Type

OBSERVATIONAL

Conditions

Postoperative Pain Management RATS Surgery

Summary

This is a pilot study in which a total of 6 people will participate. This study aims to optimize the postoperative pain management of an anatomically minimally invasive lung resection (RATS) by comparing 2 pain-relieving techniques. As standard, an intercostal block is placed at the end of the procedure by injecting a local anesthetic at the site where the patient will be operated on. This study compares the previous method with the use of cryotherapy as an intercostal block. This technique uses cryo probes and blocks postoperative pain for 1-3 months. By comparing both techniques, it is examined whether cryotherapy requires less pain medication and is therefore more effective.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two pain-blocking techniques used after minimally invasive lung removal surgery: a rhomboid intercostal nerve block (R-ICNB) versus a costotransverse block (C-ICNB). Both are injections near nerves in the chest that aim to reduce post-surgical pain, and researchers want to find out which works better. **You may be eligible if...** - You are 18 or older - You can give informed consent and fill out questionnaires in Dutch - You are having minimally invasive (keyhole) anatomical lung surgery **You may NOT be eligible if...** - You need removal of more than one full lung lobe, or you have a congenital lung abnormality or lung infection - You have been taking strong opioid painkillers for more than 3 months for a pre-existing condition - There is a high risk your surgery will need to be converted to open chest surgery - You have had previous chest surgery - You have advanced kidney disease (GFR below 30 mL/min) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.